The Shanghai Stock Exchange has cancelled a hearing to review Swiss agrichemicals and seeds group Syngenta‘s initial share offering (IPO) plan, a filing posted on the exchange showed.
Syngenta, which planned to raise 65 billion yuan ($9.44 billion) in its Shanghai flotation, was bought for $43 billion by ChemChina in 2017 and folded into Sinochem Holdings Corp in 2021.
